| Literature DB >> 32446440 |
Rebecca Grzadzinski1, Denisse Janvier2, So Hyun Kim2.
Abstract
Significant advancements have been made in early intervention programs for children with Autism spectrum disorder (ASD). However, measuring treatment response for children with ASD is difficult due to the heterogeneity of changes in symptoms, which can be subtle, especially over a short period of time. Here we outline the challenge of evaluating treatment response with currently available measures as well as newly developed or refined measures that may be useful in clinical trials for young children with ASD. Continued development of treatment outcome measures will help the field identify and compare efficacious interventions and tailor treatments for children with ASD.Entities:
Year: 2020 PMID: 32446440 PMCID: PMC7248125 DOI: 10.1016/j.spen.2020.100806
Source DB: PubMed Journal: Semin Pediatr Neurol ISSN: 1071-9091 Impact factor: 1.636